What is the share price of Affine Formulations Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Affine Formulations Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Affine Formulations?

The latest standalone P/E ratio of Affine Formulations as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Affine Formulations Ltd?

The latest standalone P/B ratio of Affine Formulations Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Affine Formulations Ltd?

The 52-week high of Affine Formulations Ltd is Rs. 0.00 and the 52-week low is Rs. 0.00.

Affine Formulations Ltd Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Affine Formulations Ltd
Brand: Affine Formulations

Affine Formulations Ltd

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹1.6

TTM Sales

₹25.1 Cr.

Book Value per Share

₹15.3

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

11.21%

Return on Capital Employed (ROCE)

13.29%

Return on Assets (ROA)

3.95%

Operating Profit Margin

11.5%

Net Profit Margin

3.88%

Gross Profit Margin

7.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

3.5%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-2.7%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-8.41%

Asset Quality

Promoter Holding

53.78%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹3 Cr.

Equity

₹6 Cr.

Face Value

₹10

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
ROCE % ⓘ	12.9%	12.1%	10%	14.1%	13.3%	-
Growth Parameters ⓘ
Sales ⓘ	21.6	31.3	32.4	24.3	25.1	25
Sales YoY Gr.	-	45.4%	3.5%	-25.1%	3.5%	-
Adj EPS ⓘ	1.3	1.2	0.6	1.8	1.6	1.6
YoY Gr.	-	-12.2%	-46.1%	187.1%	-8.4%	-
BVPS (₹) ⓘ	10.3	11.3	11.9	13.7	15.3	15.3
Adj Net Profit ⓘ	0.7	0.7	0.4	1.1	1	1
Cash Flow from Ops. ⓘ	0.5	0.5	0.9	2.1	0.1	-
Debt/CF from Ops. ⓘ	18.9	19.9	11.5	4.5	120	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-7.1%	3.5%
Adj EPS ⓘ	NA	NA	12.3%	-8.4%
BVPSⓘ	NA	NA	10.7%	11.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
Return on Equity % ⓘ	12.8	11	5.4	13.9	11.2	10.7
Op. Profit Mgn % ⓘ	10.7	6.9	6.8	12.2	11.5	NAN
Net Profit Mgn % ⓘ	3.4	2.2	1.2	4.4	3.9	3.9
Debt to Equity ⓘ	1.7	1.5	1.4	1.1	1.1	-
Working Cap Days ⓘ	0	182	194	267	286	0
Cash Conv. Cycle ⓘ	0	119	126	170	188	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Sales	21.55	31.33	32.43	24.29	25.14
Operating Expenses ⓘ +	19.25	29.15	30.23	21.34	22.26
Manufacturing Costs	0.36	0.39	0.43	0.24	0.25
Material Costs	18.13	27.85	28.80	20.18	20.77
Employee Cost	0.59	0.68	0.76	0.69	0.82
Other Costs ⓘ	0.17	0.24	0.24	0.22	0.42
Operating Profit ⓘ	2.30	2.17	2.20	2.96	2.88
Operating Profit Margin (%)	10.7%	6.9%	6.8%	12.2%	11.5%
Other Income ⓘ +	0.02	0.06	0.05	0.04	0.11
Exceptional Items ⓘ	0	0	0	0	0
Interest ⓘ	1.21	1.21	1.21	1.05	1.12
Depreciation ⓘ	0.30	0.27	0.58	0.58	0.57
Profit Before Tax ⓘ	0.81	0.75	0.46	1.38	1.30
Tax ⓘ	0.07	0.06	0.09	0.31	0.33
Profit After Tax	0.74	0.69	0.37	1.07	0.98
PAT Margin (%)	3.4%	2.2%	1.2%	4.4%	3.9%
Adjusted EPS (₹)	1.3	1.2	0.6	1.8	1.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

Valuation of Affine Formulations - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Equity and Liabilities
Shareholders Fund +	5.79	6.77	7.14	8.21	9.19
Share Capital ⓘ	0.94	1	1	1	6
Reserves ⓘ	4.85	5.77	6.14	7.21	3.19
Debt +	9.06	9.67	9.75	9.12	9.97
Long Term Debt	4.60	5.27	4.64	4.61	5.42
Short Term Debt	4.46	4.40	5.12	4.51	4.55
Minority Interest	0	0	0	0	0
Trade Payables	4.28	5.35	5.27	5.10	6.44
Others Liabilities ⓘ	1.63	1.05	1.01	0.73	0.63
Total Liabilities ⓘ	20.75	22.84	23.17	23.16	26.23
Fixed Assets
Net Fixed Assets ⓘ +	5.87	5.64	5.07	4.56	4.17
Gross Block	7.24	7.28	7.28	7.35	7.54
Accumulated Depreciation	1.37	1.64	2.22	2.80	3.36
CWIP ⓘ	0	0	0	0	0
Investments ⓘ	0	0	0	0	0
Inventories	6.35	8.46	8.73	9.46	8.16
Trade Receivables	7.72	7.75	8.64	8.08	13.18
Cash Equivalents	0.36	0.54	0.36	0.79	0.43
Others Assets ⓘ	0.45	0.45	0.37	0.27	0.28
Total Assets ⓘ	20.75	22.84	23.17	23.16	26.23

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Cash Flow From Operating Activity ⓘ +	0.53	0.49	0.87	2.05	0.08
PBT ⓘ	0.81	0.75	0.46	1.38	1.30
Adjustment ⓘ	1.50	1.46	1.77	1.61	1.67
Changes in Working Capital ⓘ	-1.78	-1.71	-1.22	-0.55	-2.47
Tax Paid ⓘ	-0	-0.01	-0.15	-0.38	-0.41
Cash Flow From Investing Activity ⓘ +	-0.07	-0.01	0.08	0.06	-0.17
Capex	-0.01	-0.04	-0.01	-0.07	-0.18
Net Investments	0	0	0	0	0
Others ⓘ	-0.07	0.03	0.09	0.12	0.01
Cash Flow From Financing Activity ⓘ +	-0.33	-0.31	-1.13	-1.68	-0.27
Net Proceeds from Shares ⓘ	0	0.30	0	0	0
Net Proceeds from Borrowing ⓘ	-1.23	0.67	-0.63	-0.03	0.81
Interest Paid ⓘ	-1.21	-1.21	-1.21	-1.05	-1.12
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	2.12	-0.06	0.71	-0.60	0.04
Net Cash Flow ⓘ	0.12	0.18	-0.17	0.43	-0.36

Financial Ratio

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Ratios
ROE (%)	12.78	10.96	5.38	13.94	11.21
ROCE (%)	12.86	12.13	9.96	14.08	13.29
Asset Turnover Ratio	1.04	1.44	1.41	1.05	1.02
PAT to CFO Conversion(x)	0.72	0.71	2.35	1.92	0.08
Working Capital Days
Receivable Days	130.70	90.10	92.20	125.60	154.30
Inventory Days	107.50	86.30	96.80	136.70	127.90
Payable Days	86.10	63.10	67.30	93.70	101.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Affine Formulations Ltd FAQs

The current trading price of Affine Formulations on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Affine Formulations stood at ₹0.00 Cr

The latest P/E ratio of Affine Formulations as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Affine Formulations as of 31-Dec-1969 is 0.00.

The 52-week high of Affine Formulations is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Affine Formulations is ₹25.14 ( Cr.) .

Data is not available for this company.

No data found

About Affine Formulations Ltd

No data to display

Affine Formulations Ltd

Affine Formulations Ltd

10 Year X-Ray :